Healthcare -
Biotechnology - NASDAQ - US
$ 8.09
-1.17 %
$ 838 M
Market Cap
-1.45
P/E
NTLA - OPERATING INCOME
Operating Income NTLA - Intellia Therapeutics, Inc.
-534 M
LAST VALUE
-7.99%
2 YEAR CAGR
-38.10%
5 YEAR CAGR
-58.84%
10 YEAR CAGR